Methotrexate-induced acute neurotoxicity in patients with osteosarcoma: a case report
Abstract Background Methotrexate is commonly used to treat osteosarcoma and acute lymphoblastic leukemia. Methotrexate can rarely cause neurotoxicity with a wide range of presentations including seizure, hemiparesis, dysarthria, dysphagia, and more. Acute neurotoxicity typically occurs within 2–14 d...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2025-09-01
|
| Serija: | Journal of Medical Case Reports |
| Teme: | |
| Online pristup: | https://doi.org/10.1186/s13256-025-05500-y |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
